openATLANTA, GA

3D Printed Airway Splints: Pre-clinical and Clinical In Vivo Degradation and Tissue Response

National Heart Lung and Blood Institute

Description

Tracheobronchomalacia (TBM) in children is a congenital or acquired deficiency of tracheobronchial cartilages that causes dynamic airway collapse, respiratory difficulties, and, in severe cases, acute life-threatening events and death. A previous study tested a bellowed 3D printed polycaprolactone (PCL) airway splint (denoted Airway Support Device – ASD) to treat TBM with a solid arch under fatigue in vitro, in a Yucatan swine in vivo model for 1 and 2 years, and lastly to treat patients with TBM under FDA Expanded Access clearance. Both in vitro fatigue and in vivo results demonstrated that this design had a risk for fracture under growth, and in addition restricted airway growth in the pre-clinical animal model. The goal of this proposal is to 1) develop new flexible ASD designs that allow radial and longitudinal growth while reducing fracture risk and 2) develop a new computational simulation combining growth, degradation and PCL elastic-plastic damage models to predict airway growth and ASD damage both in a pre-clinical model for Aims 2 and 3 as well as for a clinical model in Aim 4. It is hypothesized that a new auxetic design will allow more airway growth and show less damage than the current ASD designs. It is also hypothesized that the new growth/degradation simulation will correctly predict the effects of ASD design on airway growth and device damage. Both hypotheses will be tested using a 6-month and 2-year large pre-clinical animal study. Patient implantation to treat TBM will be continued under expanded access. Finally, data obtained in this study will be used to support an Investigational Device Exemption (IDE) to the FDA. Project Number: 1R01HL179686-01 | Fiscal Year: 2025 | NIH Institute/Center: National Heart Lung and Blood Institute (NHLBI) | Principal Investigator: Scott Hollister (+2 co-PIs) | Institution: GEORGIA INSTITUTE OF TECHNOLOGY, ATLANTA, GA | Award Amount: $709,172 | Activity Code: R01 | Study Section: Bioengineering, Technology and Surgical Sciences Study Section[BTSS] View on NIH RePORTER: https://reporter.nih.gov/project-details/1R01HL17968601

Interested in this grant?

Sign up to get match scores, save grants, and start your application with AI-powered tools.

Start Free Trial

Grant Details

Funding Range

$709,172 - $709,172

Deadline

June 30, 2030

Geographic Scope

ATLANTA, GA

Status
open

External Links

View Original Listing

Want to see how well this grant matches your organization?

Get Your Match Score

Get personalized grant matches

Start your free trial to save opportunities, get AI-powered match scores, and manage your applications in one place.

Start Free Trial